Sellas Life Sciences

About Σellas

Sellas Life Sciences is a healthcare-oriented global group of companies with a unique and innovative vision, which is ambitious, yet clear: to practice the medicine of tomorrow, today. In other words, we incorporate innovation throughout all our activities aiming at breakthroughs that will have a significant impact on the thinking and practicing of healthcare worldwide.

Our international team of acknowledged scientists, doctors and health professionals along with a seasoned and highly experienced pharmaceutical executive management form the core of Sellas. We strive to improve patients' quality of life through developing and commercializing cutting-edge innovative therapies.

Sellas is a Swiss based, development-stage biopharmaceutical company that acquires and develops innovative products for the treatment of various indications in cancer and the Central Nervous System (CNS). Sellas focuses on in-licensing drug candidates that are undergoing or have already completed initial (pre-) clinical testing and then seeks to further develop those drug candidates for commercial use.

Why Σellas

  • Highly Experienced Management Team
  • Innovative Therapeutics
  • Cutting-Edge Clinical Research
  • Focusing on CNS & Oncology
  • Blockbuster Therapies for rare diseases

Newsletter

Subscribe to our newsletter
* = required field